Handelsavisen
prelaunch
Companies Basic Materials 300019.SZ
30
300019.SZ Shenzhen Stock Exchange Specialty Chemicals

Chengdu Guibao Science & Technology Co Ltd

¥19,26
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,68 %
Op margin
8,7 %
ROE
10,3 %
Net margin
7,4 %
Debt / equity
0,08
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Chengdu Guibao Science & Technology Co Ltd operates in the specialty chemicals industry, producing and selling chemical products for industrial and commercial applications.

Business. Chengdu Guibao Science & Technology Co Ltd (300019.SZ) is a specialty chemicals company headquartered in Chengdu, China. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
10,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300019.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300019.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Chengdu Guibao Science & Technology Co Ltd (300019.SZ) is a specialty chemicals company headquartered in Chengdu, China. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Chengdu Guibao Science & Technology Co Ltd maintains a strong liquidity position with a current ratio of 2.08, indicating the ability to cover short-term obligations with its current assets. The company's liquidity_fpt score suggests a medium liquidity risk, with free cash flow of 127.4 million CNY and operating cash flow of 577.7 million CNY, which supports its operational flexibility. However, the company has a negative net cash position after subtracting total debt, which introduces some liquidity risk.

    Profitability metrics show a return on equity (ROE) of 10.28% and a return on assets (ROA) of 6.79%, both of which are in line with the industry's preferred metrics for specialty chemicals firms. The company's gross profit of 785.9 million CNY and operating income of 326.3 million CNY reflect a healthy margin structure, although the net income of 278.5 million CNY suggests some pressure from operating expenses.

    The company's revenue is not segmented by product or geography in the available data, but its total revenue of 3.75 billion CNY indicates a concentration in a single business line or geographic region. This lack of diversification could pose a risk if demand for its core products declines or if geopolitical factors affect its primary market.

    Looking ahead, the company's capital expenditure of -131.6 million CNY suggests a reduction in investment in physical assets, which may indicate a shift toward cost optimization or a mature phase in its growth cycle. Analysts have assigned a mean recommendation of 2.00, indicating a "hold" rating, with one "buy" recommendation and no "strong buy" or "sell" ratings. The mean EPS estimate of 0.82 CNY is slightly higher than the last actual EPS of 0.71 CNY, suggesting a modest growth outlook.

    The company's risk assessment highlights a low dilution risk, with no significant dilution sources identified in the available data. However, the negative net cash position after subtracting total debt introduces some liquidity risk, which could affect its ability to fund operations or pursue growth opportunities.

    Recent events and filings do not show any material changes in the company's operations or financial position, and there are no notable transcripts or disclosures that would suggest a shift in strategy or performance.

    Key takeaways
    • The company maintains a strong liquidity position with a current ratio of 2.08.
    • ROE of 10.28% and ROA of 6.79% indicate solid profitability relative to industry norms.
    • Revenue concentration in a single business line or geographic region introduces diversification risk.
    • Analysts have assigned a "hold" rating, with one "buy" recommendation and no "strong buy" or "sell" ratings.
    • The company's capital expenditure is negative, suggesting a focus on cost optimization.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥19,26
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥2.71B
    Net cash
    -¥203.5M
    Current ratio
    2.1
    Debt / equity
    0.1
    ROA
    6.8%
    ROE
    10.3%
    Cash conversion
    207.0%
    CapEx / revenue
    -3.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,82
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-21 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,82
    Revenueno estimateno estimate5,1B CNY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy1
    Hold0
    Sell0
    Strong sell0
    EPS surprise
    −13,5 %
    reported vs consensus · miss
    Revenue surprise
    −26,6 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin8,7 %Above median
    Net Margin7,4 %Above median
    ROE10,3 %Above P75
    Capex / Rev-3,5 %Above median
    D/E0,08Above median
    Cash Conv2,07Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Chengdu Guibao Science & Technology Co Ltd Market data — financials · 2026-05-26
    • Chengdu Guibao Science & Technology Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300019.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage